Raised Neutrophil-Lymphocyte may predict Peripheral Neuropathy among diabetics
Written By : Dr.Niharika Harsha B
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-09-15 14:00 GMT | Update On 2022-09-15 14:00 GMT
Advertisement
The neutrophil-to-lymphocyte ratio (NLR) has significantly and independently raised in Peripheral Diabetic Neuropathy patients as per the study published in the journal, 'International Journal of Diabetes in Developing Countries, 2022.'
The most common complication of Type 2 Diabetes (T2DM) is Peripheral Neuropathy. It is a chronic inflammatory condition. The ideal marker for any kind of chronic inflammatory disease including Diabetes is the Neutrophil-to-Lymphocyte ratio (NLR). So, researchers from Turkey conducted a study to evaluate the association between NLR and Peripheral Diabetic Neuropathy (PDN) and to determine whether NLR could be a new indicator of PDN in T2DM.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.